Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors.
about
Treatment of glioblastoma in elderly patients.Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 casesPhase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patientsHypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?Palliative treatment of poor prognosis patients with malignant gliomas.Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.Factors associated with survival for patients with glioblastoma with poor pre-operative functional status.Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.Treating glioblastoma patients with poor performance status: where do we go from here?Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
P2860
Q30838145-3AC1F9E2-6255-483F-B584-16AA1C340B1CQ34691877-4790A9DF-9F7B-4B6B-9F16-5909A14822DFQ34722872-F01F8EA8-C572-4527-B714-EFE37EE11EAFQ35911026-30962008-35F4-405F-A9CD-2728E5D73896Q36181943-4390FD7A-A84E-4524-8EA8-AF635A9BF2FCQ36365570-80CA5A99-8202-4917-972B-4A17B17D018FQ37038922-9D74AC45-F13D-49DE-ACAB-833FEA478CE6Q37159513-C52A0730-92D9-4E67-9C56-56A8A6A4E1FFQ37628704-F39D9D85-17E7-459B-8107-99E05D75979DQ37714903-F8DA2F4F-B60E-4CC4-B500-6A8B96EF59B8Q37959367-BF9026EB-A4BF-4001-AB19-955F3A53EB5DQ38233183-792D5E1E-F06B-4F95-8F0A-8FFA66109E7BQ38674157-90B39C40-EAF0-45F6-B2F5-030CDF428F8AQ48114988-01C8F65D-A98A-43E8-88D6-E76ED239DD7C
P2860
Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hypofractionated radiotherapy ...... utcome and prognostic factors.
@ast
Hypofractionated radiotherapy ...... utcome and prognostic factors.
@en
type
label
Hypofractionated radiotherapy ...... utcome and prognostic factors.
@ast
Hypofractionated radiotherapy ...... utcome and prognostic factors.
@en
prefLabel
Hypofractionated radiotherapy ...... utcome and prognostic factors.
@ast
Hypofractionated radiotherapy ...... utcome and prognostic factors.
@en
P2093
P1476
Hypofractionated radiotherapy ...... utcome and prognostic factors.
@en
P2093
Eric L Chang
Moshe H Maor
Pamela K Allen
Raymond E Sawaya
Victor A Levin
P304
P356
10.1016/S0360-3016(02)04522-4
P407
P577
2003-06-01T00:00:00Z